Northern Trust
TBRA

Northern Trust’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Northern Trust’s Portfolio TBRA Stock Details TBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-126,424
Closed -$5.02M – 4257
2016
Q3 		$5.02M Buy
126,424
+9,353
+8% +$104K ﹤0.01% 2516
2016
Q2 		$1.47M Buy
117,071
+76,282
+187% +$710K ﹤0.01% 3193
2016
Q1 		$333K Buy
40,789
+1,470
+4% +$11.1K ﹤0.01% 3563
2015
Q4 		$395K Buy
39,319
+18,372
+88% +$191K ﹤0.01% 3566
2015
Q3 		$202K Buy
20,947
+2,960
+16% +$41.5K ﹤0.01% 3743
2015
Q2 		$310K Sell
17,987
-461
-2% -$6.74K ﹤0.01% 3680
2015
Q1 		$202K Hold
18,448
– – ﹤0.01% 3867
2014
Q4 		$152K Hold
18,448
– – ﹤0.01% 3884
2014
Q3 		$188K Buy
18,448
+13,618
+282% +$269K ﹤0.01% 3852
2014
Q2 		$295K Buy
4,830
+2,726
+130% +$166K ﹤0.01% 3742
2014
Q1 		$237K Buy
+2,104
New +$148K ﹤0.01% 3740

Northern Trust's TBRA Position: Q4 2016 in Review

Northern Trust sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q4 2016, closing a stake of 126,424 shares — an estimated $5.02M sold.

Northern Trust first reported a position in TBRA in Q1 2014 and held it in 11 quarters. The position peaked at $5.02M in Q3 2016. 0 funds tracked by Wall St. Rank hold TBRA as of Q4 2016.

  • Northern Trust reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q4 2016 after selling out during the quarter.
  • Northern Trust sold 126,424 Tobira Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $5.02M.
  • Northern Trust first reported a position in Tobira Therapeutics, Inc. Common Stock in Q1 2014 and held it in 11 quarters.
  • Northern Trust's Tobira Therapeutics, Inc. Common Stock position peaked at $5.02M in Q3 2016.
  • 0 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q4 2016.

Based on Northern Trust's 13F filing for Q4 2016, filed 13 Feb 2017.